... biotechnology firms. The ban resulted partly from concern that some money could end up backing embryonic stem cell research. President and CEO of FluGen, , said : "We would love to have the opportunity to speak to the fund manager, but we are ...
http://ift.tt/1m42z0W
http://ift.tt/1m42z0W
No comments:
Post a Comment